当前位置: X-MOL 学术J. Cachexia Sarcopenia Muscle › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
Journal of Cachexia, Sarcopenia and Muscle ( IF 8.9 ) Pub Date : 2022-07-14 , DOI: 10.1002/jcsm.13032
Mengmeng Song 1, 2, 3 , Qi Zhang 1, 2, 3 , Chunhua Song 4 , Tong Liu 1, 2, 3 , Xi Zhang 1, 2, 3 , Guotian Ruan 1, 2, 3 , Meng Tang 1, 2, 3 , Hailun Xie 1, 2, 3 , Heyang Zhang 1, 2, 3 , Yizhong Ge 1, 2, 3, 5 , Xiangrui Li 1, 2, 3 , Kangping Zhang 1, 2, 3 , Ming Yang 1, 2, 3 , Qinqin Li 1, 2, 3, 6 , Xiaoyue Liu 1, 2, 3 , Shiqi Lin 1, 2, 3 , Yu Xu 7 , Hongxia Xu 8 , Kunhua Wang 9, 10 , Wei Li 11 , Hanping Shi 1, 2, 3
Affiliation  

Malnutrition and systemic inflammatory responses are associated with poor overall survival (OS) in lung cancer patients, but it remains unclear which biomarkers are better for predicting their prognosis. This study tried to determine the best one among the existing common nutrition/inflammation-based indicators of OS for patients with lung cancer.

中文翻译:

晚期肺癌炎症指数是肺癌患者总生存期的最佳炎症生物标志物

营养不良和全身炎症反应与肺癌患者较差的总生存期 (OS) 相关,但尚不清楚哪些生物标志物更能预测其预后。本研究试图确定肺癌患者现有常见的基于营养/炎症的 OS 指标中的最佳指标。
更新日期:2022-07-14
down
wechat
bug